HealthMay 18, 2021

Healthcare Technology Report names Wolters Kluwer’s Karen Kobelski to top 25 women leaders in healthcare software

The Top 25 honor recognizes “women leaders who have been integral in anticipating the unique needs of healthcare systems, companies, and professionals, recognizing the necessity for interoperability, security, and usability within embedded and frequently complex digital infrastructures.

Wolters Kluwer, Health, a leading global provider of trusted clinical technology and evidence-based solutions, today announced that Karen Kobelski, Vice President and General Manager for Clinical Surveillance Compliance & Data Solutions, has been ranked among the Top 25 Women Leaders in Healthcare Software of 2021, an award granted by The Healthcare Technology Report.

According to The Healthcare Technology Report, the Top 25 honor recognizes “women leaders who have been integral in anticipating the unique needs of healthcare systems, companies, and professionals, recognizing the necessity for interoperability, security, and usability within embedded and frequently complex digital infrastructures. Notably, they have also contributed meaningfully to the growth of their organizations, in many cases leading to marked increases in revenue during their tenures.”

“I am honored to receive this award, and I am grateful for the industry recognition of my team’s efforts,” said Kobelski. “Leading my team to develop technology that helps providers and payers improve patient care and make medical information accessible to all has been very rewarding. I’m proud of the positive impact we have made on clinical workflows and outcomes.

“In my career, I’ve been inspired by many talented women. Karen is certainly one of them. She has been truly impressive especially in the past year when I reflect on the difficulties and crossroads our employees and our customers have faced,” said Stacey Caywood, CEO Wolters Kluwer Health and Global Growth Markets and CEO of Health Learning, Research & Practice. “Karen is a proven leader in focusing on customer-first innovations, and her impact is reflected in the success of not only her business unit, but also the teams she leads in developing Health solutions adopted by our customers.”

With over 25 years of experience, Kobelski oversees an innovative healthcare software solutions business focused on improving patient care and making clinical data interoperable and actionable to customers across the healthcare ecosystem. In this role, Kobelski is driving innovation in clinical surveillance software solutions by marrying artificial intelligence with deep domain expertise to help hospital clinicians rapidly identify and treat “at-risk” patients. These include Sentri7, which enables opioid and antimicrobial stewardship programs. Under her leadership, her team was recently awarded Frost & Sullivan’s 2021 New Product Innovation Award for these innovative clinical surveillance solutions. Kobelski is also responsible for the Health Language portfolio of clinical data quality solutions that uses artificial intelligence to improve accessibility and interoperability.

A Six Sigma Black Belt, Kobelski holds an MBA from Harvard Business School and a bachelor’s degree from Georgetown University.

About Wolters Kluwer

Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software solutions and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services.

Contacts
André Rebelo
Andre Rebelo
Director, External Communications
Health
Solutions
Sentri7® Pharmacy
Sentri7 Pharmacy identifies patients early and accurately to improve patient care, safety, and drive pharmacy cost savings by optimizing medication therapies.
Empower your pharmacy team to impact patient care through evidence-based recommendations, standardizing practices via pharmacy-specific workflows, and using robust analytics to drive improvements in medication therapy, Opioid Stewardship, and Antimicrobial Stewardship.
Back To Top